Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
839.1 USD | +0.88% | +2.91% | +43.90% |
03:36pm | US FDA panel to vote on data, risk profile of Lilly Alzheimer's drug | RE |
01:00am | Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.90% | 749B | |
+39.24% | 605B | |
-6.64% | 351B | |
+19.63% | 328B | |
+8.00% | 292B | |
+11.75% | 216B | |
-2.45% | 214B | |
+1.56% | 167B | |
+7.00% | 165B | |
+1.13% | 123B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Eli Lilly and : , GSK and Vir Biotechnology Collaborate on Combining Two COVID-19 Therapies